{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:54:55Z","timestamp":1758812095731},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atypical pathogens (AP), present in some patients with community-acquired pneumonia (CAP), are intrinsically resistant to betalactam drugs, the mainstay of empirical antibiotic treatment. Adding antibiotic coverage for AP increases the risk of adverse effects and antimicrobial selection pressure, while withholding such coverage may worsen the prognosis if an AP is causative. A clinical model predicting the presence of AP would allow targeting atypical coverage for patients most likely to benefit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a secondary analysis of a multicentric randomized controlled trial that included 580 adults patients hospitalized for CAP. A predictive score was built using independent predictive factors for AP identified through multivariate analysis. Accuracy of the score was assessed using area under the receiver operating curve (AUROC), sensitivity, and specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Prevalence of AP was 5.3%. Age\u2009&lt;\u200975\u00a0years (OR 2.7, 95% CI 1.2\u20136.2), heart failure (OR 2.6, 95% CI 1.1\u20136.1), absence of chest pain (OR 3.0, 95% CI 1.1\u20138.2), natremia\u2009&lt;\u2009135\u00a0mmol\/L (OR 3.0, 95% CI 1.4\u20136.6) and contracting the disease in autumn (OR 2.7, 95% CI 1.3\u20135.9) were independently associated with AP. A predictive score using these factors had an AUROC of 0.78 (95% CI 0.71\u20130.85). A score of 0 or 1 (present in 33% of patients) had 100% sensitivity and 35% specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Use of a score built on easily obtained clinical and laboratory data would allow safe withholding of atypical antibiotic coverage in a significant number of patients, with an expected positive impact on bacterial resistance and drug adverse effects.<\/jats:p>\n                <jats:p><jats:italic>Trial registration: <\/jats:italic>NCT00818610.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07423-1","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T13:03:48Z","timestamp":1651583028000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia"],"prefix":"10.1186","volume":"22","clinical-trial-number":[{"clinical-trial-number":"nct00818610","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Aline","family":"Chauffard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Bridevaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Prendki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Reny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Stirnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"7423_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","volume":"12","author":"S Shoar","year":"2020","unstructured":"Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020;12:11.","journal-title":"Pneumonia (Nathan)"},{"issue":"1","key":"7423_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, et al. Pneumonia. Nat Rev Dis Primers. 2021;7(1):25.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"7423_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10096-014-2067-1","volume":"33","author":"A Torres","year":"2014","unstructured":"Torres A, et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065\u201379.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"7423_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00134-016-4394-4","volume":"42","author":"C Cilloniz","year":"2016","unstructured":"Cilloniz C, et al. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016;42(9):1374\u201386.","journal-title":"Intensive Care Med"},{"issue":"12","key":"7423_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1136\/thx.44.12.1031","volume":"44","author":"BM Farr","year":"1989","unstructured":"Farr BM, et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax. 1989;44(12):1031\u20135.","journal-title":"Thorax"},{"issue":"10","key":"7423_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1164\/rccm.200603-350OC","volume":"175","author":"FW Arnold","year":"2007","unstructured":"Arnold FW, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086\u201393.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"7423_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijmm.2006.05.003","volume":"296","author":"N Wellinghausen","year":"2006","unstructured":"Wellinghausen N, et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol. 2006;296(7):485\u201391.","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"7423_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/cid\/cir515","volume":"53","author":"L Senn","year":"2011","unstructured":"Senn L, et al. Does respiratory infection due to Chlamydia pneumoniae still exist? Clin Infect Dis. 2011;53(8):847\u20138.","journal-title":"Clin Infect Dis"},{"key":"7423_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2334-9-62","volume":"9","author":"H von Baum","year":"2009","unstructured":"von Baum H, et al. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"7423_CR10","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.chest.2020.12.013","volume":"159","author":"J Allgaier","year":"2021","unstructured":"Allgaier J, et al. Risk factors, management, and outcomes of Legionella pneumonia in a large, nationally representative sample. Chest. 2021;159(5):1782\u201392.","journal-title":"Chest"},{"issue":"5","key":"7423_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, et al. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415\u201327.","journal-title":"N Engl J Med"},{"issue":"7","key":"7423_CR12","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"7423_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s15006-017-9278-1","volume":"159","author":"S Ewig","year":"2017","unstructured":"Ewig S, Giesa C. Update: guidelines for the treatment and prevention of adult community-acquired pneumonia 2016: what is new? MMW Fortschr Med. 2017;159(3):51\u20132.","journal-title":"MMW Fortschr Med"},{"issue":"Suppl 6","key":"7423_CR14","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, et al. Guidelines for the management of adult lower respiratory tract infections\u2013full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1-59.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"7423_CR15","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","volume":"174","author":"N Garin","year":"2014","unstructured":"Garin N, et al. beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med. 2014;174(12):1894\u2013901.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"7423_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"7423_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"7423_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1440-1843.2009.01637.x","volume":"14","author":"G Lui","year":"2009","unstructured":"Lui G, et al. Role of \u201catypical pathogens\u201d among adult hospitalized patients with community-acquired pneumonia. Respirology. 2009;14(8):1098\u2013105.","journal-title":"Respirology"},{"issue":"Suppl 2","key":"7423_CR19","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1086\/314058","volume":"31","author":"JF Plouffe","year":"2000","unstructured":"Plouffe JF. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis. 2000;31(Suppl 2):S35\u20139.","journal-title":"Clin Infect Dis"},{"key":"7423_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2466-9-4","volume":"9","author":"R Fiumefreddo","year":"2009","unstructured":"Fiumefreddo R, et al. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med. 2009;9:4.","journal-title":"BMC Pulm Med"},{"issue":"17","key":"7423_CR21","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.2169\/internalmedicine.0491-17","volume":"57","author":"T Saraya","year":"2018","unstructured":"Saraya T, et al. A novel diagnostic scoring system to differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia. Intern Med. 2018;57(17):2479\u201387.","journal-title":"Intern Med"},{"issue":"4","key":"7423_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1086\/376627","volume":"37","author":"N Fernandez-Sabe","year":"2003","unstructured":"Fernandez-Sabe N, et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis. 2003;37(4):483\u20139.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7423_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1378\/chest.113.5.1195","volume":"113","author":"N Sopena","year":"1998","unstructured":"Sopena N, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest. 1998;113(5):1195\u2013200.","journal-title":"Chest"},{"issue":"1","key":"7423_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/MD.0b013e31827f6104","volume":"92","author":"D Viasus","year":"2013","unstructured":"Viasus D, et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore). 2013;92(1):51\u201360.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"7423_CR25","doi-asserted-by":"publisher","first-page":"1010.e11","DOI":"10.1016\/j.amjmed.2014.03.042","volume":"127","author":"S Haubitz","year":"2014","unstructured":"Haubitz S, et al. Ruling out Legionella in community-acquired pneumonia. Am J Med. 2014;127(10):1010.e11-9.","journal-title":"Am J Med"},{"issue":"2","key":"7423_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1378\/chest.13-0162","volume":"145","author":"F Arancibia","year":"2014","unstructured":"Arancibia F, et al. Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago Chile. Chest. 2014;145(2):290\u20136.","journal-title":"Chest"},{"issue":"4","key":"7423_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1378\/chest.100.4.1007","volume":"100","author":"V Falco","year":"1991","unstructured":"Falco V, et al. Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest. 1991;100(4):1007\u201311.","journal-title":"Chest"},{"issue":"4","key":"7423_CR28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1378\/chest.120.4.1064","volume":"120","author":"SK Gupta","year":"2001","unstructured":"Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest. 2001;120(4):1064\u201371.","journal-title":"Chest"},{"issue":"11","key":"7423_CR29","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3201\/eid2011.131872","volume":"20","author":"A Farnham","year":"2014","unstructured":"Farnham A, et al. Legionnaires\u2019 disease incidence and risk factors, New York, New York, USA, 2002\u20132011. Emerg Infect Dis. 2014;20(11):1795\u2013802.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"7423_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061036","volume":"8","author":"C Garcia-Vidal","year":"2013","unstructured":"Garcia-Vidal C, et al. Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia. PLoS ONE. 2013;8(4): e61036.","journal-title":"PLoS ONE"},{"issue":"4","key":"7423_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/resp.12978","volume":"22","author":"C Cilloniz","year":"2017","unstructured":"Cilloniz C, et al. Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22(4):778\u201385.","journal-title":"Respirology"},{"issue":"7","key":"7423_CR32","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3201\/eid2307.161429","volume":"23","author":"E Kenagy","year":"2017","unstructured":"Kenagy E, et al. Risk factors for Legionella longbeachae Legionnaires\u2019 disease New Zealand. Emerg Infect Dis. 2017;23(7):1148\u201354.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"7423_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00103-011-1287-0","volume":"54","author":"H von Baum","year":"2011","unstructured":"von Baum H, Luck C. Community-acquired Legionella pneumonia: data from the CAPNETZ study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(6):688\u201392.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"7","key":"7423_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3109\/23744235.2015.1021830","volume":"47","author":"T Roed","year":"2015","unstructured":"Roed T, Schonheyder HC, Nielsen H. Predictors of positive or negative Legionella urinary antigen test in community-acquired pneumonia. Infect Dis (Lond). 2015;47(7):484\u201390.","journal-title":"Infect Dis (Lond)"},{"issue":"11","key":"7423_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jiac.2017.09.001","volume":"23","author":"N Miyashita","year":"2017","unstructured":"Miyashita N, et al. Clinical presentation of legionella pneumonia: evaluation of clinical scoring systems and therapeutic efficacy. J Infect Chemother. 2017;23(11):727\u201332.","journal-title":"J Infect Chemother"},{"issue":"7","key":"7423_CR36","doi-asserted-by":"publisher","first-page":"ofz268","DOI":"10.1093\/ofid\/ofz268","volume":"6","author":"R Bolliger","year":"2019","unstructured":"Bolliger R, et al. Validation of a Prediction Rule for Legionella Pneumonia in Emergency Department Patients. Open Forum Infect Dis. 2019;6(7):ofz268.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"7423_CR37","first-page":"116","volume":"13","author":"BA Cunha","year":"1998","unstructured":"Cunha BA. Clinical features of legionnaires\u2019 disease. Semin Respir Infect. 1998;13(2):116\u201327.","journal-title":"Semin Respir Infect"},{"issue":"7","key":"7423_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/civ1214","volume":"62","author":"NJ Gadsby","year":"2016","unstructured":"Gadsby NJ, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817\u201323.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"7423_CR39","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/cid\/cix549","volume":"65","author":"DM Musher","year":"2017","unstructured":"Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis. 2017;65(10):1736\u201344.","journal-title":"Clin Infect Dis"},{"key":"7423_CR40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02375-2017","author":"V Prendki","year":"2018","unstructured":"Prendki V, et al. Low-dose CT for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.02375-2017.","journal-title":"Eur Respir J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07423-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T13:05:00Z","timestamp":1651583100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7423"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07423-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committees of all participating hospitals and Swissmedic, the Swiss regulatory agency for therapeutic products, approved the protocol of the original study (CER 06-259), which was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}